Skip to main content
Equibles
AYTU $2.38 +3.48%
AYTU logo

AYTU · Aytu Biopharma, Inc

Track AYTU — free

Use AYTU with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AYTU

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.38 +0.08 (+3.48%) At close · Aug 14
Market Cap
$25.55M
Shares
10.73M
All earnings calls

Earnings call · FY2023 Q1

Aytu Biopharma, Inc Q1 FY2023 Earnings Call

Aytu Biopharma, Inc Q1 FY2023 Earnings Call

Concluded Nov 14, 2022
Nov 14, 2022 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $27.66M +26.3% YoY
Diluted EPS -$0.28
Gross margin 65.2% +8.3 pp YoY
Net income -$701,000

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 14, 2022 10-Q report Filed Feb 21, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Rx$18.65M +34.4% YoY
Consumer Health$9.00M +12.3% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)